ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L02AE02 | G | Leuprorelin acetate - 5mg | 8731 | 74116/1 | LEUPRO-SANDOZ | 5mg | 1 per three months | Implant | SC | Khalil Fattal & Fils S.A.L. | Ever Pharma Jena GmbH | Germany | 9,108,032 L.L | 19.35 | D | Hexal AG | Germany | 2/5/2024 | 70 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L02AE02 | G | Leuprorelin acetate - 5mg | 6319 | 166796/11 | LEUPRO-SANDOZ | 5mg | 1 per three months | Implant | SC | Khalil Fattal & Fils S.A.L. | Ever Pharma Jena GmbH | Germany | 9,108,032 L.L | 19.35 | D | Sandoz Pharmaceuticals GmbH | Germany | 2/5/2024 | 70 |